CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 375 | -94.1% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 6,375 | +45.7% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 4,375 | -20.5% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 5,500 | -8.3% | 0.00% | – |
| Q4 2021 | $16,000 | -63.6% | 6,000 | -40.0% | 0.00% | – |
| Q3 2021 | $44,000 | -57.3% | 10,000 | -43.8% | 0.00% | -100.0% |
| Q2 2021 | $103,000 | +9.6% | 17,800 | +31.9% | 0.00% | 0.0% |
| Q1 2021 | $94,000 | +3033.3% | 13,500 | +1534.4% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 826 | +65.2% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | – | 500 | – | 0.00% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |